Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03620617

Effect of Raspberry on Gut Microbiota and Metabolic Syndrome

Beneficial Effects of Raspberry in Overweight/Obese Individuals: Potential Role of the Gut Microbiota in Alleviating the Metabolic Syndrome

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
59 (actual)
Sponsor
Laval University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

There is growing evidence that nutritional intervention with dietary polyphenols can positively modulate the gut microbiota to improve cardiometabolic health. Whether the beneficial effects of raspberry on obesity and the metabolic syndrome can be linked to their potential impact on the gut microbiota and intestinal integrity remains speculative at this time. Moreover, the mechanisms of action underlying health benefits associated to raspberry consumption are still unknown. The investigators are thus proposing to combine the study of metagenomics, transcriptomics and metabolomics to test whether a prebiotic activity of raspberry can play a role in the prevention of obesity-linked metabolic syndrome in a clinical setting.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTRaspberry supplementDuring the 8-week protocol, participants will be invited either to consume 280g of frozen raspberries daily (morning and evening). The daily dose is equivalent to 2 cups of raspberries.

Timeline

Start date
2018-01-08
Primary completion
2019-08-22
Completion
2027-12-01
First posted
2018-08-08
Last updated
2025-12-26

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03620617. Inclusion in this directory is not an endorsement.